Lumicell, Inc.
Lumicell, Inc.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-06-01 | NCT07616856 | |
| Post-market Safety Study of LUMISIGHT | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Neoplasms by Site, Skin and Connective Tissue Diseases, anaphylaxis, breast disorder, breast neoplasm, drug allergy, immune system disorder, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-05-07 | NCT07572162 | |
| Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, esophageal cancer, esophageal disorder, gastric cancer, gastric neoplasm, intestinal disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-16 | NCT02584244 |